EverSource Wealth Advisors »

Atea Pharmaceuticals shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $199k 57k 3.50
2025-09-30 $436k 151k 2.89
2025-06-30 $344k 94k 3.67
2025-03-31 $347 116 2.99
2024-09-30 $230 69 3.35
2024-06-30 $450 118 3.82

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Value Etf Etf (VTV)
Vanguard Ftse Developed Markets Etf Etf (VEA)
iShares Gold Trust ETF Etf (IAU)
State Street Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Apple Stock (AAPL)
Praxis Impact Large Cap Growth Etf Etf (PRXG)
Nvidia Corporation Stock (NVDA)
Praxis Impact Large Cap Value Etf Etf (PRXV)
Apollo Global Mgmt Stock (APO)
Tesla Stock (TSLA)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Fidelity Wise Origin Bitcoin Fund Etf (FBTC)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)

View all positions for EverSource Wealth Advisors

Top funds holding Atea Pharmaceuticals

BlackRock
BML Capital Management
FMR
Tang Capital Management
Vanguard Group
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Acadian Asset Management
Renaissance Technologies
Two Sigma Advisers
Jpmorgan Chase & Co
Charles Schwab Investment Management
Northern Trust

View all funds holding Atea Pharmaceuticals